Stereotactic body radiation therapy with simultaneous integrated boost for prostate cancer: does MRI-targeted biopsy alter the boost field?
CONCLUSIONS: Compared to systematic TRUS biopsy, implementation of prebiopsy prostate MRI and FB allows for safe and feasible SBRT in patients with significantly larger prostate volumes without increasing SIB cancer-directed treatment volumes, oncologic outcomes, quality of life measures, or treatment-related toxicities.PMID:34657654
Source: Canadian Journal of Urology - Category: Urology & Nephrology Authors: Andrew M Fang Zachary R Burns Alexander P Nocera Rex A Cardan Jeffrey W Nix Kristin K Porter Andrew M McDonald Soroush Rais-Bahrami Source Type: research
More News: Adenocarcinoma | Burns | Canada Health | Cancer | Cancer & Oncology | Gastroenterology | MRI Scan | Prostate Cancer | Radiation Therapy | Toxicology | Ultrasound | Urology & Nephrology